from Reuters: Health News https://reut.rs/2ElCXd9
Thursday, February 28, 2019
Novartis faces shareholder criticism over drug prices at AGM
Novartis's shift into high-tech drugs won praise for giving new options to patients but criticism for prices that may run into the millions of dollars as the Swiss drugmaker faced investors at its annual general meeting on Thursday.
from Reuters: Health News https://reut.rs/2ElCXd9
from Reuters: Health News https://reut.rs/2ElCXd9
Subscribe to:
Post Comments (Atom)
-
(Reuters Health) - More than half of heart failure patients who visit the emergency room don't receive prompt follow-up care, and a Cana...
-
WEIGHT LOSS supplements could help overweight or obese patients with the diet plans. You could lose weight and avoid weight gain by adding...
-
A U.S. appeals court on Wednesday declined a request by Johnson & Johnson for an temporary restraining order blocking sales of generic v...
No comments:
Post a Comment